javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD9.3804723130130.1055
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD5.8659127672781.3594
Domestic EquitiesDIVI LABORATORIES LTD5.797012060080.4040
Domestic EquitiesABBOTT INDIA LTD5.41232795375.0678
Domestic EquitiesCIPLA LTD5.179351275471.8368
Domestic EquitiesMAX HEALTHCARE INSTITUTE LTD4.804669048866.6390
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD4.55967734563.2411
Domestic EquitiesRAINBOW CHILDRENS MEDICARE LTD4.521545433862.7123
Domestic EquitiesDR REDDYS LABORATORIES LTD4.023542811655.8049
Domestic EquitiesMANKIND PHARMA LTD3.768422001852.2675
Domestic EquitiesFORTIS HEALTHCARE LTD3.409650935147.2907
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD3.262820475345.2545
Domestic EquitiesBAYER CROPSCIENCE LTD3.10449548143.0572
Domestic EquitiesLUPIN LTD2.759516877838.2738
Domestic EquitiesSAI LIFE SCIENCES LTD2.726332597837.8134
Domestic EquitiesSYNGENE INTERNATIONAL LTD2.655083313236.8244
Domestic EquitiesALKEM LABORATORIES LTD2.42356113733.6131
Domestic EquitiesJ.B.CHEMICALS & PHARMACEUTICALS LTD2.237514318331.0335
Domestic EquitiesGLOBAL HEALTH LTD2.199125653230.5017
Domestic EquitiesFDC LTD2.118472548329.3821
Domestic EquitiesAJANTA PHARMA LTD1.88848942626.1920
Domestic EquitiesNEULAND LABORATORIES LTD1.88661531326.1669
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD1.79594113224.9095
Domestic EquitiesDR. LAL PATH LABS LTD1.681014505123.3155
Domestic EquitiesMETROPOLIS HEALTHCARE LTD1.640340966422.7507
Domestic EquitiesPFIZER LTD1.62774909422.5759
Domestic EquitiesSANOFI INDIA LTD1.45746526820.2142
Domestic EquitiesGILLETTE INDIA LTD1.34612329018.6704
Domestic EquitiesVIJAYA DIAGNOSTIC CENTRE LTD1.141012094915.8262
Domestic EquitiesTORRENT PHARMACEUTICALS LTD1.02043208614.1525
Domestic EquitiesCONCORD BIOTECH LTD0.771910184210.7056
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD0.58231668488.0771
Domestic EquitiesJUBILANT PHARMOVA LTD0.5474763037.5921
Domestic EquitiesSUMITOMO CHEMICAL INDIA LTD0.49421366646.8544
Domestic EquitiesCORONA REMEDIES LTD0.4533374956.2868
Domestic EquitiesHDFC LIFE INSURANCE CO. LTD0.4007934465.5582
Domestic EquitiesPI INDUSTRIES LTD0.3589179394.9781
Domestic EquitiesIPCA LABORATORIES LTD0.00272490.0380
Total 99.3049 1377.3468
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET0.4632 6.4250
Cash & Cash Equivalents and Net AssetsA) REPO0.2318 3.2156
Total 0.6951 9.6406
 
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.